Emmaus Life Sciences, Inc. (EMMA) Reports In-Line Q2 EPS

Emmaus Life Sciences, Inc. (OTC: EMMA) reported Q2 EPS of ($0.03), in-line with the analyst estimate of ($0.03). Revenue for the quarter came in at $10.76 million versus the consensus estimate of $5 million.

For earnings history and earnings-related data on Emmaus Life Sciences, Inc. (EMMA) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Helius Medical Technologies (HSDT) Misses Q2 EPS by 31c
• Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c